financetom
Business
financetom
/
Business
/
First Nordic Provides "Positive" Top of Bedrock Drill Results at Nippas Target
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
First Nordic Provides "Positive" Top of Bedrock Drill Results at Nippas Target
May 25, 2025 10:02 PM

10:54 AM EDT, 04/30/2025 (MT Newswires) -- First Nordic Metals ( FNMCF ) on Wednesday provided "positive" base-of-till/top-of-bedrock drilling results and a Q2 diamond drill plan at its high-priority Nippas target on its Storjuktan project, located in Vasterbotten County, northern Sweden on the Gold Line belt.

Among highlights, in a statement it noted the drilling identified highly anomalous kilometric-scale bedrock and till anomalism on three parallel structural trends at the Nippas target, including bedrock results of up to 2.66 ppm gold. The company said the targets consist of a cumulative total of 5.2 km of anomalous sub-parallel structural corridors identified for follow up diamond drilling.

"Our recent BoT/ToB drilling at Nippas continues to support this area as an exciting diamond drill target and we are now preparing to mobilize a diamond drill rig here within the coming weeks," said First Nordic Chief Executive Taj Singh. "Our current diamond drilling at the Aida target, which had the objective of aggressively testing the strike extent of the gold mineralized corridor there, continues to progress well and we expect to release a first batch of results shortly."

The company plans to complete an initial 5,000 metres of diamond drilling at the Nippas target using one diamond drill rig and is prepared to begin to test its first two targets in Q2 of 2025.

Shares of the company were last seen down 1.2% at $0.42 on the TSX Venture Exchange.

Price: 0.42, Change: -0.01, Percent Change: -1.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: New York Times Explores Partnerships to Expand Subscriber Base
Market Chatter: New York Times Explores Partnerships to Expand Subscriber Base
Jan 21, 2025
12:32 PM EST, 01/21/2025 (MT Newswires) -- The New York Times ( NYT ) has been discussing potential bundled subscription partnerships with smaller publishers to expand its subscriber base in the US, Axios reported on Tuesday, citing sources familiar with the matter. The partnerships would involve offering access to its lifestyle subscription products, such as games, cooking, and sports. The...
Complete Solaria Surges On Heels Of Q4 Revenue Report, SunPower Acquisition
Complete Solaria Surges On Heels Of Q4 Revenue Report, SunPower Acquisition
Jan 21, 2025
Complete Solaria, Inc. ( CSLR ) shares are trading higher after the company released its preliminary fourth-quarter results. The Fremont, California-based company disclosed that its quarterly revenue escalated to $81.1 million (vs. consensus of $50 million) from $5.5 million in the third quarter on a standalone basis and surpassed the company guidance of $80 million. Notably, in the third quarter...
B. Riley Financial to Fully Redeem 6.375% Senior Notes
B. Riley Financial to Fully Redeem 6.375% Senior Notes
Jan 21, 2025
12:31 PM EST, 01/21/2025 (MT Newswires) -- B. Riley Financial ( RILY ) said Tuesday it would be fully redeeming its 6.375% senior notes due Feb. 28. The company said it would return the principal plus any accrued and unpaid interest on the notes to lenders. After the redemption, the notes will cease to trade on Nasdaq, the company said....
Johnson & Johnson Secures FDA Approval For Nasal Spray as Depression Monotherapy
Johnson & Johnson Secures FDA Approval For Nasal Spray as Depression Monotherapy
Jan 21, 2025
12:31 PM EST, 01/21/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Tuesday that the US Food and Drug Administration approved nasal spray Spravato as the first-ever stand-alone therapy for major depressive disorder. The product, which targets the glutamate neurotransmitter in the brain, can now be used by adults living with psychiatric disorders and who have had an...
Copyright 2023-2026 - www.financetom.com All Rights Reserved